Routes of
administration Oral Biological half-life 7-27 hours PubChem CID 3012003 | ATC code none CAS Number 59859-58-4 Molar mass 311.42 g/mol | |
 | ||
Legal status In general: uncontrolled | ||
Femoxetine (INN) (tentative brand name Malexil; developmental code name FG-4963) is a drug related to paroxetine that was being developed as an antidepressant by Danish pharmaceutical company Ferrosan in 1975 before acquisition by Novo Nordisk. It acts as a selective serotonin reuptake inhibitor (SSRI). Development was halted to focus attention on paroxetine instead, given femoxetine's inability to be administered as a daily pill.
Both femoxetine and paroxetine were invented in the 1970s by Jorgen Buus-Lassen (Jørgen Anders Christensen name on the patents though). Jorgen Buus-Lassen's name is on the pharmacology paper though.
After Ferrosan's acquisition, femoxetine died from neglect.
References
Femoxetine Wikipedia(Text) CC BY-SA